Despite some limitations, including the limited sample size, long follow-up, and data concerning LDH as an indicator of tumour burden, the study brings some important knowledge to the field, showing that there are immunological effects correlated to the use of CDK4/6 inhibitor as a single agent. The gene discussed is CDK4; the disease is neoplasm.